Target intelligence / Profile preview

Brain-expressed X-linked protein 3 (BEX3)

Target
BEX3
Molecular classification
Other (intracellular signaling/scaffold protein)
01

Overview

Brain-expressed X-linked protein 3 (BEX3) is a member of the BEX protein family, comprised of small, intrinsically disordered proteins predominantly expressed in the brain[1][2]. BEX3 is known to interact with several cellular proteins and acts as an intracellular hub for cell signaling, particularly involved in the regulation of apoptosis, cell cycle dynamics, and the expression of the neurotrophin receptor TrkA[1][2]. It can dimerize and shuttles between cytoplasm and nucleus, which is mediated by a nuclear export sequence (NES)[2]. In neuronal cells, BEX3 positively regulates TrkA expression and thereby supports nerve growth factor (NGF)-dependent cell survival and differentiation, but its overexpression can also promote apoptosis when NGF is absent[2]. BEX3 has been implicated as a molecular player in neurodegenerative disorders and cancer, but it is not known to be directly targeted by any drugs and is not currently an an established biomarker[1][2]. Molecularly, BEX3 is predicted to be largely disordered, with regions capable of forming α-helices and coiled-coil structures, enabling its function as a signaling scaffold and mediator of protein interactions[1].

Other names
BEX3DXS6984ENADENGFRAP1BexHGR74Hero20Brain-expressed X-linked protein 3Nerve growth factor receptor-associated protein 1Ovarian granulosa cell 13.0 kDa protein HGR74p75NTR-associated cell death executor
02

Biological functions

Regulation of apoptosisCell cycleCell signalingRegulation of neurotrophin receptor expressionModulation of neuronal differentiation and survival
03

Disease associations

Neurodegenerative diseaseCancer

Beyond the preview

Go deeper on Brain-expressed X-linked protein 3 (BEX3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-expressed X-linked protein 3 (BEX3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call